An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device

BACKGROUND: Poor adherence to disease-modifying drugs is associated with an increased risk of relapse in patients with multiple sclerosis. However, adherence is difficult to assess objectively. RebiSmart(®) (Merck Serono SA, Geneva, Switzerland), a device for subcutaneous (sc) injection of interfero...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Helen, Webster, Julie, Larkin, Anne Marie, Parkes, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062562/
https://www.ncbi.nlm.nih.gov/pubmed/24966669
http://dx.doi.org/10.2147/PPA.S54986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062562/
https://www.ncbi.nlm.nih.gov/pubmed/24966669
http://dx.doi.org/10.2147/PPA.S54986

Ejemplares similares